RUA — Rua Bioscience Cashflow Statement
0.000.00%
- NZ$6.02m
- NZ$5.99m
- NZ$0.09m
Annual cashflow statement for Rua Bioscience, fiscal year end - June 30th, NZD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.183 | 0.691 | 0.696 | 0.104 | 0.755 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.63 | -4.45 | -6.84 | -5.92 | -3.74 |
Capital Expenditures | -5.02 | -1.4 | -0.4 | -0.074 | -0.001 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.05 | -13 | 5.99 | 6.75 | 2.21 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2.97 | -14.4 | 5.59 | 6.67 | 2.21 |
Financing Cash Flow Items | -0.574 | -1.54 | -0.045 | -0.019 | -0.017 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6.36 | 18.3 | -0.209 | -0.12 | -0.095 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.236 | -0.578 | -1.46 | 0.632 | -1.63 |